Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Study points to genetic test for mental disorders:

This article was originally published in Clinica

Executive Summary

A study showing specific genetic changes in the brains of people with schizophrenia and bipolar disorder could lead to a new diagnostic test for these diseases. Researchers at the University of Cambridge, UK, report in The Lancet (September 6) that sufferers of the disorders exhibited reduced expression of key genes involved in producing brain cells called oligodendrocytes and myelin, the protein that insulates them. The findings also show that the two diseases may be more closely related than previously thought.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063525

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel